Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
IFNAR1 3454 INTERFERON ALFACON-1 CHEMBL1201557 agonist, binder TdgClinicalTrial, ChemblInteractions, TEND, DrugBank 11752352, 17139284, 17016423, 12528473
IFNAR1 3454 GLATIRAMER ACETATE CHEMBL1201507 PharmGKB
IFNAR1 3454 INTERFERON ALFA-N1 CHEMBL2108509 agonist TdgClinicalTrial, TEND, DrugBank 11752352, 17139284, 17016423, 10822464, 19955815
IFNAR1 3454 INTERFERON ALFA-2B CHEMBL1201558 agonist, binder TdgClinicalTrial, ChemblInteractions, TEND, DrugBank 10567921, 11752352, 17139284, 17016423
IFNAR1 3454 PEGINTERFERON BETA-1A CHEMBL2108677 agonist ChemblInteractions
IFNAR1 3454 INTERFERON ALFA-N3 CHEMBL2109047 agonist TdgClinicalTrial, ChemblInteractions, TEND, DrugBank 15898717, 11752352, 17139284, 17016423, 19955815
IFNAR1 3454 PEGINTERFERON ALFA-2A CHEMBL1201560 agonist TdgClinicalTrial, ChemblInteractions, DrugBank 16953837, 11752352, 15898717, 19955815
IFNAR1 3454 PEGINTERFERON ALFA-2B CHEMBL1201561 agonist ChemblInteractions, DrugBank 17139284, 17016423, 11752352, 16953837, 15898717, 19955815
IFNAR1 3454 INTERFERON ALFA-2A CHEMBL2108508 agonist TdgClinicalTrial, ChemblInteractions, TEND, DrugBank 15898717, 18230610
IFNAR1 3454 INTERFERON ALFA CHEMBL2108506 TdgClinicalTrial, DrugBank
IFNAR1 3454 SIFALIMUMAB CHEMBL1743069 TdgClinicalTrial
IFNAR1 3454 INTERFERON BETA-1B CHEMBL1201563 agonist TdgClinicalTrial, ChemblInteractions, TEND, DrugBank 11752352, 10049744
IFNAR1 3454 ALBINTERFERON ALFA-2B CHEMBL2107842 agonist ChemblInteractions
IFNAR1 3454 INTERFERON BETA CHEMBL2108510 TdgClinicalTrial
IFNAR1 3454 INTERFERON BETA-1A CHEMBL1201562 agonist TdgClinicalTrial, ChemblInteractions, DrugBank 12034032, 10049744, 16912135, 11747625

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
IFNAR1 rs1012335 G glatiramer acetate efficacy yes Significant only when also combined with the HLA-DRB1*15 allele, rs1800469 allele A and rs333 del allele. Risk of not responding to the drug was significantly increased in individuals carrying this allele combination. Allele G is associated with decreased response to glatiramer acetate in people with Multiple Sclerosis as compared to allele C. 22111603 827823546